BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32119062)

  • 1. The screening of blood by Aspergillus PCR and galactomannan ELISA precedes BAL detection in patients with proven and probable IA.
    Springer J; Löffler J; Einsele H; White PL
    Med Mycol; 2020 Aug; 58(6):856-858. PubMed ID: 32119062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
    Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
    Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
    Couchepin J; Brunel AS; Jaton K; Meylan P; Bochud PY; Lamoth F
    Mycoses; 2018 Jun; 61(6):350-354. PubMed ID: 29453853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays.
    Guegan H; Robert-Gangneux F; Camus C; Belaz S; Marchand T; Baldeyrou M; Gangneux JP
    J Infect; 2018 Feb; 76(2):196-205. PubMed ID: 29248586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-positive galactomannan antigen testing in pulmonary nocardiosis.
    Haran A; Temper V; Assous M; Bergel M; Chahanian N; Elinav H; Korem M
    Med Mycol; 2021 Feb; 59(2):206-209. PubMed ID: 32944777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies.
    Hadrich I; Mary C; Makni F; Elloumi M; Dumon H; Ayadi A; Ranque S
    Med Mycol; 2011 Jul; 49(5):489-94. PubMed ID: 21108574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
    Meersseman W; Lagrou K; Maertens J; Wilmer A; Hermans G; Vanderschueren S; Spriet I; Verbeken E; Van Wijngaerden E
    Am J Respir Crit Care Med; 2008 Jan; 177(1):27-34. PubMed ID: 17885264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.
    Verweij PE; Latgé JP; Rijs AJ; Melchers WJ; De Pauw BE; Hoogkamp-Korstanje JA; Meis JF
    J Clin Microbiol; 1995 Dec; 33(12):3150-3. PubMed ID: 8586691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid sample from suspected patients of invasive pulmonary aspergillosis.
    Malhotra S; Kumari R; Chauhan AK; Bhatia NK; Kaur A; Sharma B; Duggal N
    Indian J Pathol Microbiol; 2021; 64(4):732-734. PubMed ID: 34673593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.
    Loeffler J; Hafner J; Mengoli C; Wirth C; Heussel CP; Löffler C; White PL; Ullmann AJ; Michel D; Wiegering V; Wölfl M; Schlegel PG; Einsele H; Springer J; Eyrich M
    J Clin Microbiol; 2017 Jan; 55(1):101-109. PubMed ID: 27795339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
    Heldt S; Prattes J; Eigl S; Spiess B; Flick H; Rabensteiner J; Johnson G; Prüller F; Wölfler A; Niedrist T; Boch T; Neumeister P; Strohmaier H; Krause R; Buchheidt D; Hoenigl M
    J Infect; 2018 Sep; 77(3):235-241. PubMed ID: 29972764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.